首页> 外国专利> POORLY SOLUBLE DRUG-CONTAINING RELEASE-CONTROLLED POLYMERIC NANOPARTICLE FORMULATION

POORLY SOLUBLE DRUG-CONTAINING RELEASE-CONTROLLED POLYMERIC NANOPARTICLE FORMULATION

机译:含难溶药物的释放控制的聚合物纳米颗粒配方

摘要

The present invention relates to a release-controlled polymeric nanoparticle formulation containing biphenyl-dimethyl-dicarboxylate, a poorly soluble drug, and more particularly, to a nano-sized polymer formulation having a particle size distribution of narrow range, in which the biphenyl-dimethyl-dicarboxylate, a poorly soluble drug, is impregnated in biodegradable polymer and the surface of the formulation is coated with an emulsifier. The polymeric nanoparticle formulation according to the present invention can be effectively used in the treatment of hepatic disease since the formulation enhances the dissolution rate of biphenyl-dimethyl-dicarboxylate which is a poorly soluble drug to increase bioavailability, and releases drugs gradually to keep the drugs at a constant density in blood over a long period of time. The polymeric nanoparticle formulation of the present invention may prevent an excessive use of biphenyl-dimethyl-dicarboxylate caused due to the low dissolution rate in a body and low bioavailability of conventional formulations containing biphenyl-dimethyl-dicarboxylate.
机译:本发明涉及含有难溶性药物联苯基-二甲基-二羧酸酯的控制释放的聚合物纳米颗粒制剂,更特别地,涉及具有窄范围的粒径分布的纳米尺寸的聚合物制剂,其中联苯-二甲基-二羧酸盐,一种难溶药物,被浸渍在可生物降解的聚合物中,并且制剂的表面被乳化剂包被。根据本发明的聚合物纳米颗粒制剂可以有效地用于治疗肝病,因为该制剂提高了难溶性药物联苯-二甲基-二羧酸盐的溶解速率,从而提高了生物利用度,并逐渐释放药物以保持药物的活性。在很长一段时间内保持恒定的血液密度。本发明的聚合物纳米颗粒制剂可以防止由于在体内的低溶解速率和包含联苯-二甲基-二羧酸的常规制剂的低生物利用度而引起的联苯-二甲基-二羧酸二苯酯的过量使用。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号